Alamudi Samira Husen, Kimoto Michiko, Hirao Ichiro
Institute of Bioengineering and Bioimaging (IBB), Agency for Science, Technology and Research (ASTAR) 31 Biopolis Way, Nanos #07-01 Singapore 138669 Singapore
RSC Med Chem. 2021 Jul 24;12(10):1640-1649. doi: 10.1039/d1md00199j. eCollection 2021 Oct 20.
Nucleic acid aptamers, also regarded as chemical antibodies, show potential as targeted therapeutic and delivery agents since they possess unique advantages over antibodies. Generated by an iterative selection and amplification process from oligonucleotide libraries using cultured cells, the aptamers bind to their target molecules expressed on the cell surface. Excitingly, most aptamers also demonstrate a cell-internalizing property in native living cells, allowing them to directly enter the cells endocytosis depending on the target. In this review, we discuss selection methods in generating cell-internalizing aptamers a cell-based selection process, along with their challenges and optimization strategies. We highlight the cellular uptake routes adopted by the aptamers and also their intracellular fate after the uptake, to give an overview of their mechanism of action for applications as promising pharmacological agents.
核酸适配体,也被视为化学抗体,因其相对于抗体具有独特优势,故而展现出作为靶向治疗和递送剂的潜力。通过使用培养细胞从寡核苷酸文库中进行迭代筛选和扩增过程产生的适配体,会与细胞表面表达的靶分子结合。令人兴奋的是,大多数适配体在天然活细胞中也表现出细胞内化特性,这使它们能够根据靶标通过内吞作用直接进入细胞。在本综述中,我们讨论了生成细胞内化适配体的筛选方法——一种基于细胞的筛选过程,以及它们面临的挑战和优化策略。我们着重介绍了适配体所采用的细胞摄取途径以及摄取后它们在细胞内的命运,以概述其作为有前景的药物制剂的作用机制。